View of Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients

Return to Article Details Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients Download Download PDF